Heron Financial Group’s Quest Diagnostics DGX Stock Holding History

Heron Financial Group’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$536K	Hold	3,812	–	–	0.29%	78
2023 Q1	$539K	Sell	3,812 -240	-6%	-$34.3K	0.3%	74
2022 Q4	$626K	Sell	4,052 -70	-2%	-$10.1K	0.42%	52
2022 Q3	$506K	Hold	4,122	–	–	0.31%	74
2022 Q2	$548K	Sell	4,122 -190	-4%	-$25.9K	0.33%	70
2022 Q1	$590K	Hold	4,312	–	–	0.31%	71
2021 Q4	$583K	Hold	4,312	–	–	0.31%	71
2021 Q3	$627K	Hold	4,312	–	–	0.35%	64
2021 Q2	$569K	Hold	4,312	–	–	0.33%	74
2021 Q1	$558K	Buy	4,312 +155	+4%	+$19.1K	0.34%	70
2020 Q4	$515K	Buy	4,157 +50	+1%	+$6.09K	0.36%	68
2020 Q3	$474K	Sell	4,107 -191	-4%	-$22.6K	0.38%	69
2020 Q2	$502K	Hold	4,298	–	–	0.45%	55
2020 Q1	$387K	Hold	4,298	–	–	0.4%	61
2019 Q4	$483K	Buy	+4,298	New	+$448K	0.4%	60

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Heron Financial Group's DGX Position: Q2 2023 in Review

Heron Financial Group held its Quest Diagnostics (DGX) position steady in Q2 2023 at 3,812 shares worth $536K. The position accounts for 0.29% of the portfolio, ranked #78.

Heron Financial Group first reported a position in DGX in Q4 2019 and has held it in 15 quarters since. The position peaked at $627K in Q3 2021. 819 funds tracked by Wall St. Rank hold DGX as of Q2 2023.

Heron Financial Group held 3,812 shares of Quest Diagnostics worth $536K as of Q2 2023.
Heron Financial Group left its Quest Diagnostics share count unchanged in Q2 2023.
Quest Diagnostics made up 0.29% of Heron Financial Group's portfolio in Q2 2023, its #78 holding.
Heron Financial Group first reported a position in Quest Diagnostics in Q4 2019 and has held it in 15 quarters since.
Heron Financial Group's Quest Diagnostics position peaked at $627K in Q3 2021.
819 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2023.

Based on Heron Financial Group's 13F filing for Q2 2023, filed 10 Aug 2023.